Anderson, S.
, Barker, P.
and Hadfield, M.
(2002),
Cytonectin Expression in Alzheimer's Disease, Journal of Neuropathology and Experimental Neurology
(Accessed April 17, 2026)
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Cytonectin Expression in Alzheimer's Disease
Published
Author(s)
S J. Anderson, , M G. Hadfield
Abstract
Cytonectin is a novel 35,000 molecular weight protein that displays remarkable ion-independent adherence properties. This consigns it to a family of well-known adherence molecules essential for cell communication and the development of 3-dimensional tissue structures. Cytonectin is expressed in a variety of organs and tissues, being evolutionarily conserved from human to avian species. It is hypothesized to act as a do not attack signal molecule that prevents tissue destruction by cells of momocyte lineage. This paper describes the properties of cytonectin and its proposed role in normal and disease staes. The propein is overexpressed in Alzheimer disease entorhinal cortex as compared to normal age-matched controls. It is also detected in tissues from patients with Down syndrome and leukemia. Its presence in all 3 of these related conditions may prove important to their etiopathogensis.Citation
Journal of Neuropathology and Experimental Neurology
Volume
61
Issue
3
Pub Type
Journals
Keywords
down syndrome, protein
Citation
Issues
If you have any questions about this publication or are having problems accessing it, please contact [email protected].
Created February 28, 2002, Updated October 12, 2021